$Cassava Sciences (SAVA.US)$ This is a Bullish Factual State...
$Cassava Sciences(SAVA.US$ This is a Bullish Factual Statement For SAVA" Approximately 89% of patients in Cassava’s ongoing Phase 3 program have elected to continue with open-label treatment with simufilam after completion of the blinded trials. " FDA Approved Extension. Shorts, Adrian, Jessee, BIk, Bredt, Jordan have no value with their statements. FDA and patient testimony to stay on SAVA to treat Alzheimer's safely and with efficacy. These shorts delayed the trials and caused many people to die not being treated with SAVA. Shorts & HF are going to get exactly what they deserve.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
